Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedMalignant fibrous histiocytoma is added as a related term, and the Genetic and Rare Diseases Information Center resources are now listed.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated to v3.4.3 and previous revision v3.4.2 removed.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 in the page header. No substantive trial content or details were altered.SummaryDifference0.0%

- Check60 days agoChange DetectedThe revision label at the top of the page changes from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check67 days agoChange DetectedMinor UI and metadata updates include adding a glossary option and a revision label (v3.4.0) with slight capitalization changes; these changes do not modify core study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.